Publicaciones en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (77)

2024

  1. Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties

    European Journal of Medicinal Chemistry, Vol. 277

2023

  1. C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease

    Cells, Vol. 12, Núm. 5

  3. IGF-1 Controls Metabolic Homeostasis and Survival in HEI-OC1 Auditory Cells through AKT and mTOR Signaling

    Antioxidants, Vol. 12, Núm. 2

  4. Neuroprotective properties of queen bee acid by autophagy induction

    Cell Biology and Toxicology, Vol. 39, Núm. 3, pp. 751-770

2022

  1. A CRISPR/Cas9-engineered avatar mouse model of monocarboxylate transporter 8 deficiency displays distinct neurological alterations

    Neurobiology of Disease, Vol. 174

  2. Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy

    Cells, Vol. 11, Núm. 15

  3. Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades

    Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4727-4751

  4. Temperature modulates systemic and central actions of thyroid hormones on BAT thermogenesis

    Frontiers in Physiology, Vol. 13

2021

  1. The immune system through the lens of alcohol intake and gut microbiota

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2020

  1. Intranasal delivery of Thyroid hormones in MCT8 deficiency

    PloS one, Vol. 15, Núm. 7, pp. e0236113

  2. Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease

    Aging, Vol. 12, Núm. 17, pp. 16690-16708

  3. Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson’s Disease

    Molecular Neurobiology, Vol. 57, Núm. 2, pp. 806-822

  4. Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

    European Journal of Medicinal Chemistry, Vol. 190

2019

  1. Adult Mice Lacking Mct8 and Dio2 Proteins Present Alterations in Peripheral Thyroid Hormone Levels and Severe Brain and Motor Skill Impairments

    Thyroid, Vol. 29, Núm. 11, pp. 1669-1682

  2. Intracerebroventricular administration of the thyroid hormone analog TRIAC increases its brain content in the absence of MCT8

    PLoS ONE, Vol. 14, Núm. 12

  3. Methodological approach for the evaluation of FOXO as a positive regulator of antioxidant genes

    Methods in Molecular Biology (Humana Press Inc.), pp. 61-76

  4. New flavonoid–N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 712-727

  5. Novel approaches for the treatment of alzheimer’s and parkinson’s disease

    International Journal of Molecular Sciences, Vol. 20, Núm. 3

  6. Protein kinase C δ regulates the depletion of actin at the immunological synapse required for polarized exosome secretion by T cells

    Frontiers in Immunology, Vol. 10, Núm. APR